Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia

Objective: Previous studies showed that offering BRCA mutation testing to population subgroups at high risk of harbouring the mutation may be cost effective, yet no evidence is available for low- or middle-income countries (LMIC) and in Asia. We estimated the cost effectiveness of BRCA mutation test...

Full description

Bibliographic Details

Main Authors:	Lim, Ka Keat, Yoon, Sook Yee, Mohd Taib, Nur Aishah, Shabaruddin, Fatiha Hana, Dahlui, Maznah, Woo, Yin Ling, Thong, Meow Keong, Teo, Soo Hwang, Chaiyakunapruk, Nathorn
Format:	Article
Published:	Springer Verlag 2018
Subjects:	R Medicine
Online Access:	http://eprints.um.edu.my/21446/ https://doi.org/10.1007/s40258-018-0384-8
Tags:	Add Tag No Tags, Be the first to tag this record!